Uppsala University
Robert Frithiof
The study aims to investigate organ dysfunction and biomarkers in patients with suspected or verified COVID-19 during intensive care at Uppsala University Hospital.
COVID-19
Organ Dysfunction Syndrome Sepsis
Organ Dysfunction Syndrome, Multiple
Septic Shock
Acute Kidney Injury
Acute Respiratory Distress Syndrome
Consenting patients with suspected or verified SARS-COV-2 infection, COVID-19, will undergo daily blood, urine and sputum sampling during their stay in intensive care. Data on organ dysfunction will be collected through the electronic patient journal and electronic patient data management system. The collected samples will be analysed for a panel of potential biomarkers that will be correlated to organ dysfunction and clinical outcome.
| Study Type : | OBSERVATIONAL |
| Estimated Enrollment : | 300 participants |
| Official Title : | Uppsala Intensive Care Study of Mechanisms for Organ Dysfunction in Covid-19 |
| Actual Study Start Date : | 2020-03-12 |
| Estimated Primary Completion Date : | 2026-12-31 |
| Estimated Study Completion Date : | 2026-12-31 |
Information not available for Arms and Intervention/treatment
| Ages Eligible for Study: | 18 Years |
| Sexes Eligible for Study: | ALL |
| Accepts Healthy Volunteers: |
Want to participate in this study, select a site at your convenience, send yourself email to get contact details and prescreening steps.
RECRUITING
Uppsala University Hospital
Uppsala, Sweden, 75185